Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has announced that the company held its Ordinary general assembly meeting on Thursday, 23-04-2015 corresponding to 04-07-1436, while The Assembly approved the following agenda:

1. Agree on the report of the Board of Directors for the financial year ended 31/12/2014.

2. Approval of the company's balance sheet on 31/12/2014 and the profit and loss account for the period for 1/1/2014 to 31/12/2014.

3. Discharge of the members of the Board of Directors for the same period.

4. Approval of the dividend as proposed by the Board of Directors by 1.5 riyal per share by 15% and the legitimacy of profits must be to shareholders registered in the company records at the end of the trading day of the assembly.

5. Approval of the disbursement of SR 1,400,000 as a reward to the members of the Board of Directors by 200 thousand riyals for each member for the financial year ended 31/12/2014.

6. Approvals of the auditor selection from the candidates nominated by the Audit Committee to review the financial statements for the fiscal year 2015 and quarterly financial statements and determine his remuneration.

7. Licensing of the Ordinary General Assembly of the Company on the practice of Dr. Essa Jasim Al Khalifah member of the Board of Directors SPIMACO-his work as a managing Director of the Kuwait Saudi Pharmaceutical Industries company and Member of the Board of the National Company for Pharmaceutical Industry. He is representing the Government of Kuwait in Board of Directors Acdima Company (a joint government-owned company) while Acdima owned 20.49% of Spimaco .

distributed by